Supercritical fluid chromatography (SFC) has emerged as a powerful and versatile technique in analytical chemistry, particularly for the analysis of complex lipids and fatty acids. Over the past decade, innovations in instrumentation, column technology, and detection have propelled SFC from a niche method into a mainstream tool for lipidomics, food quality control, and biopharmaceutical characterization. Its ability to separate non-volatile, thermally labile, and structurally diverse lipid species with high speed and low solvent consumption makes it an attractive alternative to gas chromatography (GC) and liquid chromatography (LC). This article reviews the fundamental principles, recent technological breakthroughs, practical applications, and future directions of SFC in lipid and fatty acid analysis.

Fundamentals of Supercritical Fluid Chromatography

SFC employs a supercritical fluid—most commonly carbon dioxide (CO2)—as the mobile phase. Above its critical temperature (31.1 °C) and pressure (73.8 bar), CO2 enters a state where it exhibits gas‑like viscosity and diffusivity combined with liquid‑like solvating power. This unique combination enables rapid mass transfer and efficient separation of analytes with a wide range of polarities. The solvating strength of supercritical CO2 can be tuned by adjusting pressure and temperature, and by adding polar modifiers such as methanol, ethanol, or isopropanol. Modifier gradients are commonly employed to elute more polar lipid classes, including phospholipids and sphingolipids. Modern SFC systems operate at pressures up to 600 bar and temperatures up to 80 °C, providing a broad operating window for method development.

Recent Technological Advances

High‑Resolution Mass Spectrometry (HRMS) Coupling

The coupling of SFC with high‑resolution mass spectrometry—such as quadrupole‑time‑of‑flight (Q‑TOF) and Orbitrap instruments—has revolutionized lipid profiling. HRMS provides accurate mass measurements (<1 ppm) that enable confident identification of lipid species and their regioisomers. For example, SFC‑MS/MS workflows can distinguish between sn‑1 and sn‑2 fatty acid positions in triacylglycerols, a critical need in nutritional and metabolic studies. Recent research in the Journal of Chromatography A demonstrated the use of SFC‑Q‑TOF for untargeted lipidomics of human plasma, identifying over 400 lipid species from 15 classes in under 30 minutes.

Advanced Stationary Phases and Column Chemistry

Column technology has evolved significantly to address the separation of complex lipid mixtures. Conventional bare silica or C18 phases are being supplemented by bonded phases with tailored selectivity for lipid class separation. For instance, 2‑ethylpyridine (2‑EP), diol, and propyl‑cyano phases offer orthogonal selectivity for phospholipids, glycolipids, and neutral lipids. Sub‑2‑μm fully porous particles and superficially porous (core‑shell) particles provide high efficiency while maintaining moderate backpressure. A notable innovation is the development of ultra‑performance convergence chromatography (UPC²), which uses sub‑2‑μm particles and operates at ultra‑high pressures to achieve separation speeds comparable to UHPLC.

Automation and High‑Throughput Platforms

Modern SFC systems incorporate autosamplers capable of handling many samples, precise backpressure regulators (BPR), and column switching valves for multiplexed analysis. These features enable high‑throughput workflows essential for large‑scale cohort studies or routine quality control. Miniaturized SFC systems, sometimes termed capillary or micro‑SFC, reduce solvent consumption to microliters per run and allow coupling with nano‑ESI‑MS for enhanced sensitivity. Automated method development software, which rapidly optimizes modifier gradient, temperature, and pressure, is now integrated into commercial platforms, shortening method setup from days to hours.

Applications in Lipid and Fatty Acid Analysis

Lipidomics and Biomarker Discovery

Untargeted lipidomics aims to comprehensively profile lipid species in biological matrices. SFC‑MS excels here because it can separate lipids across a wide polarity range in a single run. In a landmark study, Bamba et al. in Analytical Chemistry used SFC‑MS to profile lipids in mammalian serum, covering free fatty acids, phospholipids, and triacylglycerols with high reproducibility. The technique is now applied to discover lipid biomarkers for diseases such as type 2 diabetes, non‑alcoholic fatty liver disease (NAFLD), and certain cancers. For example, altered lysophosphatidylcholine and ceramide profiles have been identified in plasma from patients with early‑stage colorectal cancer using SFC‑MS workflows.

Food Quality and Authenticity Control

Fatty acid composition is a key determinant of nutritional value and shelf‑life in edible oils, dairy products, and processed foods. SFC provides faster analysis of fatty acid methyl esters (FAMEs) compared to traditional GC methods, with run times often under 10 minutes. Moreover, SFC can directly analyze free fatty acids and acylglycerols without derivatization, simplifying sample preparation. Recent work applied SFC‑UV to quantify omega‑3 and omega‑6 fatty acids in fish oil capsules, achieving relative standard deviations below 2 %. The technique is also used to detect adulteration of expensive oils (e.g., olive oil) by profiling the intact triacylglycerol fingerprint.

Clinical and Diagnostic Applications

In clinical laboratories, SFC is gaining traction for quantifying fatty acids and lipids related to inborn errors of metabolism and cardiovascular risk. Plasma free fatty acid (FFA) profiles are measured to assess insulin resistance and diabetic complications. SFC‑MS permits the simultaneous determination of FFA, hydroxy‑, and oxylipins, which are bioactive lipid mediators. A recent article in Talanta reported an SFC‑MS/MS method for 20 oxylipins in human plasma with limits of detection below 0.1 ng/mL, enabling robust quantification in clinical studies.

Lipid Metabolism and Plant Biochemistry

Understanding lipid biosynthesis in plants, algae, and microorganisms is important for biofuel production and nutritional improvement. SFC‑MS enables the rapid analysis of membrane lipids, storage lipids, and their precursors. Researchers have used SFC to profile glyceroglycolipids and phospholipids in microalgae under different growth conditions, revealing how nutrient stress alters lipid accumulation—information critical for optimizing algal biodiesel yields.

Comparison with Traditional Methods

Compared to gas chromatography (GC), SFC avoids the need for derivatization of non‑volatile lipids, retains thermally labile compounds (e.g., polyunsaturated fatty acids with many double bonds, oxidized lipids), and uses lower operating temperatures. However, GC still offers superior resolution for simple FAMEs and remains the reference method for fatty acid composition in many regulatory settings. SFC, on the other hand, can analyze intact triacylglycerols and polar lipids that are inaccessible to GC.

Relative to liquid chromatography (LC, especially reversed‑phase), SFC provides faster analysis times (typically 5–15 minutes vs. 20–60 minutes for lipidomic LC runs), uses less organic solvent, and often gives better peak shapes for lipids that tend to tail in LC. The trade‑off is that polar lipids, such as strongly acidic phospholipids, may require high modifier percentages that reduce the supercritical nature of the mobile phase, partially diminishing SFC’s advantage. Nevertheless, recent developments in column chemistry have mitigated this limitation.

Challenges and Considerations in Method Development

Despite its strengths, SFC for lipid analysis presents certain challenges. The solubility of very lipophilic compounds in supercritical CO₂ may be limited; additives like ammonium acetate or formic acid are often needed to improve peak shape and ionization in MS. Column selection is critical—poorly chosen phases can result in co‑elution of lipid classes. Method transfer between instruments can be difficult due to differences in BPR design and dead volumes. Standardization of retention time across laboratories still lags behind LC and GC, although recent inter‑laboratory studies are beginning to address this. Finally, the cost of high‑pressure pumping systems and the need for specialized training may hinder adoption in smaller analytical labs.

Future Perspectives

The next wave of innovation in SFC for lipid analysis is likely to focus on several areas. First, the integration of ion mobility spectrometry (IMS) with SFC‑MS adds an extra dimension of separation based on collision cross‑section, enabling the resolution of isomeric lipids that co‑elute in the chromatographic dimension. Second, open‑tube (capillary) SFC columns with inner diameters of 25–50 μm promise even faster separations and lower sample consumption. Third, the development of portable or field‑deployable SFC systems, perhaps using cryogen‑free CO₂ generation, could bring rapid lipid testing to point‑of‑care or food production facilities. Fourth, the expansion of retention time databases and machine‑learning‑driven method optimization will simplify method development for non‑expert users. As regulatory acceptance grows, SFC may become a standard technique in pharmacopoeial monographs for lipid‑based drug products and excipients.

Conclusion

Supercritical fluid chromatography has matured into a robust, high‑performance tool for the analysis of lipids and fatty acids. Recent advances in detector sensitivity, column selectivity, and automation have unlocked applications ranging from clinical biomarkers to food authenticity verification. While challenges remain in instrument standardization and method transfer, the ongoing development of new stationary phases, hyphenated techniques, and miniaturized systems suggests a promising future. As the demand for faster, greener, and more informative lipid analysis grows, SFC is well positioned to complement—and in some cases replace—traditional GC and LC methodologies in the analytical laboratory.